Brooks Laboratories heads higher after unit gets EUGMP certificate

Brooks Laboratories gained 2.87% to Rs 100.20 at 14:53 IST on BSE after the company announced that its Vadodara facility received EU good manufacturing practices (GMP) certificate.

The announcement was made during market hours today, 5 February 2018.

Meanwhile, the S&P BSE Sensex was down 360.11 points or 1.03% at 34,706.64. The BSE Small-Cap index was down 116.05 points or 0.65% at 17,731.48, outperforming the Sensex.

On the BSE, 19,015 shares were traded in the counter so far, compared with an average volume of 20,227 shares in the past one quarter. The stock had hit a high of Rs 102.55 in intraday trade. The stock had hit a low of Rs 91.50 so far during the day, which is also a 52-week low for the stock. The stock had hit a record high of Rs 162 on 8 February 2017.

The stock had underperformed the market over the past 30 days till 2 February 2018, falling 10.52% compared with 3.71% rise in the Sensex. The scrip had also underperformed the market in past one quarter, dropping 13.54% as against Sensex's 4.45% rise. The scrip had also underperformed the market in past one year, falling 30.13% as against Sensex's 24.23% rise.

The small-cap company has an equity capital of Rs 16.19 crore. Face value per share is Rs 10.

Brooks Laboratories reported net loss of Rs 3.02 crore in Q3 December 2017 compared with net profit of Rs 0.73 crore in Q3 December 2016. Net sales fell 4.1% to Rs 13.17 crore in Q3 December 2017 over Q3 December 2016.

Brooks Laboratories is a contract manufacturing pharmaceutical company.

Powered by Capital Market - Live News